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We have identified a missense mutation in the motor domain of the neuronal kinesin heavy chain gene KIF5A, in
a family with hereditary spastic paraplegia. The mutation occurs in the family in which the SPG10 locus was
originally identified, at an invariant asparagine residue that, when mutated in orthologous kinesin heavy chain
motor proteins, prevents stimulation of the motor ATPase by microtubule-binding. Mutation of kinesin orthologues
in various species leads to phenotypes resembling hereditary spastic paraplegia. The conventional kinesin motor
powers intracellular movement of membranous organelles and other macromolecular cargo from the neuronal cell
body to the distal tip of the axon. This finding suggests that the underlying pathology of SPG10 and possibly of
other forms of hereditary spastic paraplegia may involve perturbation of neuronal anterograde (or retrograde)
axoplasmic flow, leading to axonal degeneration, especially in the longest axons of the central nervous system.
The hereditary spastic paraplegias (HSPs) are a genetically
heterogeneous group of neurodegenerative disorders char-
acterized by progressive lower-limb spasticity and weak-
ness, occurring in the absence (pure HSP) or presence
(complicated HSP) of additional neurological abnormal-
ities (Reid 1999). To date, 18 loci for HSP have been
identified, including loci for autosomal dominant, auto-
somal recessive, and X-linked forms (Fink 2002). The
pathology of HSP is characterized by axonal degeneration
of motor and sensory neurons that is maximal at the distal
ends of the longest axons of the CNS (McDermott et al.
2000).
Neurons are highly polarized cells that present an ex-
treme example of the difficulties of proper intracellular
trafficking of membranous organelles and protein com-
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plexes. The longest adult human neurons have axons of
up to 1 m in length and axonal volumes that are as much
as 1,000# the volume of the neuronal cell body (Gold-
stein 2001). The microtubule cytoskeleton provides struc-
tural support for the cell and serves as the molecular rail
system for intracellular cargo trafficking. Recent data sug-
gest that the most common form of HSP (SPG4 [MIM
182601]), caused by mutations in the gene encoding spas-
tin (Hazan et al. 1999), is caused by impaired regulation
of the microtubule cytoskeleton in long axons (Errico et
al. 2002). Missense mutations in spastin were found to
cause constitutive binding of spastin to microtubules and
to lead to redistribution of the microtubule cytoskeleton,
suggesting a pathogenic mechanism of disruption of mi-
crotubule dynamics (Errico et al. 2002).
The microtubule-associated protein families of kinesins
and dyneins serve as the molecular motors that distrib-
ute intracellular cargo along microtubules, with kinesins
working in the anterograde direction and dyneins work-
ing in the retrograde direction (Hirokawa1998;Goldstein
and Yang 2000). Along with genes encodingmicrotubule-
associated proteins, those of the kinesin and dyneinmotor
complexes make compelling candidate genes for the SPG
loci in the context of the neuropathology associated with
the distal ends of the longest axons of the CNS.
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Table 1
Primers Used for KIF5A Amplification and DNA Sequencing
EXON(S)
PRIMER
ANNEALING
TEMPERATUREa
(C)
Forward Reverse Buffer 1 Buffer 2
1 tctgtccccagagactgagcacctg gaagaggatgaaggatgagcgg 60
2–6 ggccattctcccacatttc ccctaggcacatctcattcc 55
4b aagcaatggaagtccaaagg
5b cttgactccctttccggtta
7 gctgagattcttgacactgcac ccacagacaaggggtcctc 55
8 gaggaggaccccttgtctgt atcgtgccactgcaaacc 55
9 ccagccaagcatctctgtta tcaacagggaatcagaaaggat 55
10 ccatatgatcatgccccaat ctgggtgaggagaagaggaa 55
11 aagtccaccctgatgtttgg cagaaacacagcccctcttc 55
12 cctcccatactcccaaaagg tccacatttcaagcataagca 55
13 gcttcaaccgatcttcctgt ggagtgattaatccccaagc 55
14 aggcaatgtgcccaccta tcacaatgcactgaacagca 55
15 ctgcactttcccctcacagt gcgcccaacctagaatgtat 55
16 ggcggaggaatttaatgtga cccagcttttctgtccttga 55
17 aaaggaagagccccatagga gagctacatgcaaaaccttgg 55
18 and 19 cccttgttctctgttcctgct gcattgttgagggaatgaca 55
20 aatgccacaacttcgtagcc cgtccctaccccatcatattt 55
21 gtctgtggtcccagatgctt gccagataccaggtctgtcc 55
22 and 23 ttttgcagccattctgtagc agggaaagtaaaagcgaacag 55
24 and 25 ggccttttgaggaaatgaca gcatgaagttgagaaagggttt 55
26 gtggccatgtttgttttcct ggctgagtgcagtggctatt 55
27 taagatgggagagggtttgc gggcacaagggaaatttaatc 55
28 aatagtccctgccgtttgtg ggaagcagcctgacactacc 55
a Buffer 1: 10# buffer (100 mM Tris, 500 mM KCl, 10 mM MgCl2, 1% Triton X-100,
and 0.1% gelatin). Buffer 2: 10# buffer (100 mM Tris, 15 mM MgCl2, and 500 mM KCl).
b Nested sequencing primers for exons 4 and 5.
The kinesin heavy chain (KHC) proteins are part of
a multisubunit complex (kinesin-I) that acts as a plus-
end–directed microtubule motor involved in anterograde
transport of membranous organelles in nerve axons (Xia
et al. 1998; Goldstein and Yang 2000; Goldstein 2001).
This family includes conventional kinesins KIF5A (MIM
602821), KIF5B (MIM 602809), and KIF5C (MIM
604593). Whereas KIF5B exhibits ubiquitous expression
with prominent glial cell expression, KIF5A and KIF5C
are expressed exclusively in neurons. Expression of
KIF5C is restricted to a subset of neurons and includes
developmentally regulated expression in the lowermotor
neurons. In contrast, KIF5A is expressed in all neurons
and is found throughout the neuronal cytoplasm, in-
cluding in the cell body, dendrites, and axon (Kanai et
al. 2000).
An autosomal dominant locus for pure HSP (SPG10
[MIM 604187]) was originally established in a large
family and was mapped to chromosome 12 (Reid et
al. 1999). The 7-cM candidate interval, bordered by
D12S270 and D12S355, is defined by crossovers in this
single family (Reid et al. 2001). The gene for the neu-
ronal KHC protein KIF5A maps within this interval. By
virtue of its neuronal expression pattern and chromo-
somal map location, KIF5A makes a compelling can-
didate gene for SPG10.
In addition to KIF5A (table 1), we sequenced 29 other
genes (table 2) that mapped within the SPG10 candidate
interval. Although a number of polymorphic variants
(i.e., those also observed in normal population control
individuals) were identified in these 30 genes, only the
KIF5A gene exhibited a potential mutation. We identi-
fied an N256S missense mutation in the KIF5A gene in
all affected members of the family in which the SPG10
locus was originally identified (Reid et al. 1999, 2001)
but not in 220 normal control individuals (figs. 1 and
2). DNA was also available from five family members
whowere not classified as definitely affected after clinical
examination. Two of these subjects were clinically nor-
mal at ages 54 and 31 years, and one had bilateral lower-
limb hyperreflexia only, at age 17 years. None of these
three subjects had the N256S mutation. The two re-
maining subjects both had the N256S mutation. One of
these had bilateral lower-limb hyperreflexia, a unilateral
extensor plantar reflex, no clonus, and no gait abnor-
mality at age 22 years, whereas the other had bilateral
lower-limb hyperreflexia and nonsustained clonus at age
54 years. This latter patient was likely to be an obligate
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Table 2
Genes Sequenced in the SPG10 Candidate Interval
Gene Name/Description Reference Sequencea
KIF5A Kinesin heavy chain 5A, neuronal NM_004984
INHBC Inhibin b C chain preproprotein NM_005538
GALGT b-1,4-N-acetylgalactosaminyltransferase NM_001478
OS-9 Similar to mouse neurofilament protein NM_006812
AVIL Advillin NM_006576
MYO1A Myosin IA NM_005379
TAC3 Tachykinin 3 NM_013251
GDF11 Growth differentiation factor 11 NM_005811
RAB5B Member RAS oncogene family NM_002868
ERBB3 v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 NM_001982
NPFF FMFRamide-related protein precursor NM_003717
LOC51644 Copz1 mouse ortholog NM_016057
ATP5G2 ATP synthase, H transporting, mitochondrial F0 NM_005176
PPP1R1A Protein phosphatase 1, regulatory (inhibitor) subunit 1A NM_006741
PFDN5 Prefoldin 5 NM_002624
AAAS Aladin NM_015665
PDE1B Phosphodiesterase IB, calmodulin-dependent NM_000924
FLJ22055 Similar to chain B, phosphatidylinositol phosphate kinase type II b NM_024779  BG720492
KIAA0747 Mbc2 mouse ortholog NM_015292
PA2G4 Proliferation-associated 2G4, 38kD NM_006191
DKFZp564J157 Similar to mouse formin 4 NM_018457
KIAA1536 Similar to rat myosin heavy chain, neuronal NM_020898
CCT2 Chaperonin containing TCP1, subunit 2 (b) NM_006431
LOC115557 Similar to triple functional domain (PTPRF interacting) NM_133483
NEUROD4 Neurogenic differentiation 4 NM_021191
NAB2 NGFI-A binding protein 2 NM_005967
MY050 Hypothetical brain protein NM_032624
GLI Glioma-associated oncogene homolog (zinc finger protein) NM_005269
DCTN2 Dynactin 2 (p50) NM_006400
MAP3K12 Mitogen-activated protein kinase kinase kinase 12 NM_006301
a Reference sequences are available from the working draft human genome sequence database on the UCSC Genome
Bioinformatics Web site.
carrier, since one of her offspring (not available for
study) was reported to have bilateral hyperreflexia, bi-
lateral clonus, and bilateral extensor plantar reflexes.
The N256S mutation occurs at an invariant asparagine
residue in the switch II loop/helix motif within the motor
domain of the protein (fig. 3). Intriguingly, a Saccharo-
myces cerevisiae mutant isolated as a suppressor of mu-
tations in plus-end–directed mitotic kinesins has a mu-
tation in the homologous amino acid position (N650K)
in Kar3, the minus-end–directed motor of the mitotic
spindle (Hoyt et al. 1993). The mutant allele exhibits
dominance over the wild-type KAR3 allele, suggesting a
possible dominant-negative mechanism. This mutation
was subsequently shown to decouple nucleotide and mi-
crotubule binding of the motor, resulting in a block in
microtubule-dependent stimulation of motor ATPase ac-
tivity (Song and Endow 1998). The Ncd kinesin motor
ofDrosophila, engineered with the homologousmutation
(N600K), shows a similar inhibitory effect on microtu-
bule-stimulated ATPase activity and, in addition, dem-
onstrates a lack of microtubule-stimulated motility in a
gliding assay (Song and Endow 1998). The recently de-
termined crystal structures of the wild-type Kar3 protein
and the N650K mutant illustrate the critical role of this
amino acid residue in kinesin motor function (Yun et al.
2001). Upon binding to microtubules, the N650 residue
participates in the activation of ATPase, via hydrogen
bonding and side chain interactions with the switch I and
switch II regions, which form a characteristic salt bridge
in the nucleotide-binding cleft (Yun et al. 2001).
To date, only one other known family with autosomal
dominant HSP exhibits linkage to chromosome 12 (Ash-
ley-Koch et al. 2001). In this family, we were unable to
identify a mutation in the KIF5A gene, despite sequenc-
ing the entire coding region, ∼2 kb upstream of the tran-
scriptional start site, and 50 nts of intronic sequence
flanking each exon. Southern blot analysis using full-
length kinesin cDNA as a probe did not reveal evidence
of gross rearrangement, and separation of the wild-type
and mutant chromosomes (as determined by disease
haplotype) in somatic cell hybrids did not reveal deletion
of any of the KIF5A exons. In these hybrid lines, the
KIF5A transcripts from both the wild-type and mutant
chromosomes were expressed at equivalent levels. Fi-
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Figure 1 Electropherograms of sequences in the motor domain
of the KIF5A gene. The affected individual from the family in which
the SPG10 locus was originally identified (Reid et al. 1999, 2001) has
both A (wild-type) and G (mutant) at nucleotide 767. The mutation
changes the invariant asparagine at position 256 to a serine in the
switch II loop/helix region (see fig. 3).
Figure 2 Cosegregation of the A767G mutation with the spastic paraplegia phenotype in the family in which the SPG10 locus was
originally identified (Reid et al. 1999, 2001). Standard pedigree symbols are used. Genotypes at the mutation are listed as either wild-type A/
A or heterozygous mutant A/G.
nally, the transcript derived from the mutant chromo-
some did not show a novel splice variant that might be
caused by an undiscovered mutation lying deep within
an intron. Although a mutation affecting message sta-
bility or an unknown alternatively spliced exon cannot
be excluded, this family may instead harbor a mutation
in another gene mapping to the same chromosome. In
support of this conjecture, the candidate interval for this
second family is 140 cM, extending from D12S1052
(which maps to 12q) to beyond D12S1057 (which maps
to 12p). This interval includes but greatly exceeds the
7-cM interval defined in the original family. In addition,
the clinical presentations of the two families are dissim-
ilar (full clinical descriptions for each family can be
found in the articles by Reid et al. [1999] and Ashley-
Koch et al. [2001]). Most notable is an apparent age-
at-onset difference between the two families. Members
of the family in which the SPG10 locus was originally
identified were noted to have a juvenile-onset form of
the disease, with a mean age at onset of 11 years
( years; Reid et al. 1999, 2001). In contrast,10.8 9.6
members of the second family exhibit an adult onset of
the phenotype, with a mean age at onset of 30 years
( years; Ashley-Koch et al. 2001). Finally,30.4 13.4
only 2 of the 13 affected members of the original family
developed even a mild amyotrophy (muscle wasting),
whereas older affected members of the second family
exhibited moderate-to-severe amyotrophy. This degree
of amyotrophy is unusual for pure HSP. The phenotypic
differences between the two families are consistent with
the existence of a distinct locus that maps within the
140-cM candidate interval defined by the other family
showing linkage to chromosome 12.
In addition to the biochemical evidence that specific
mutations in kinesin orthologues cause loss of kinesin
motor function, loss-of-function mutations in related
KHC genes of various species cause movement defects
that are reminiscent of those observed in human spastic
paraplegias. Drosophila larvae harboring either homo-
zygous or hemizygous mutations in the KHC exhibit be-
havioral and movement defects, including a progressive
gradient of dorsoventral and anteroposterior paralysis
(Saxton et al. 1991; Hurd and Saxton 1996). Analysis of
the neurons in the mutant larvae shows aberrant accu-
mulation of membranous organelles in so-called “organ-
elle jams.” Similarly, Caenorhabditis elegans mutants
lacking either the unc-104 or the unc-116 kinesin ortho-
logues exhibit uncoordinated and slow movement (Hall
and Hedgecock 1991; Patel et al. 1993). Animals with
severe unc-104 alleles assume a tightly coiled posturewith
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Figure 3 Kinesin protein homologies in the motor region. Multiple alignment showing conserved residues (shaded), nucleotide-binding
motifs Switch I (Sw I) and Switch II (Sw II), and the switch II loop/helix region (Sack et al. 1999; Song et al. 2001). Identical residues are
shaded in dark gray, strongly similar residues in medium gray, and weakly similar residues in light gray. The KIF5A mutation in the family
with SPG10, as well as the NCD and KAR3 mutations, are indicated by the arrow. Sequence alignments of the various kinesin proteins were
performed using ClustalW (Thompson et al. 1994; EMBL-EBI European Bioinformatics Institute Web site).
periods of muscle contraction that persist for several
minutes at a time (Hall and Hedgecock 1991). In this
case, the neuron cell bodies of unc-104 mutants accu-
mulate synaptic vesicles in the cytoplasm. In the mouse,
disruption of the gene encoding the kinesin motor
KIF1Bb, implicated in mitochondrial transport, results in
multiple neurological abnormalities in homozygous ani-
mals and a “staggering” gait defect in adult heterozygotes
(Zhao et al. 2001). The human KIF1Bb gene was sub-
sequently shown to be mutated in a family with Charcot-
Marie-Tooth disease type 2A (MIM 118210), an auto-
somal dominant peripheral neuropathy characterized by
weakness and atrophy of distal muscles, depressed tendon
reflexes, and mild sensory loss (Zhao et al. 2001). Finally,
deletion of the related kif5B gene in the mouse results in
embryonic lethality and abnormal perinuclear clustering
of mitochondria in cells derived from the extraembryonic
membranes (Tanaka et al. 1998).
On the basis of the genetic and biochemical studies
of kinesin proteins in diverse species, we propose that
the KIF5A mutation identified in SPG10 will result in
a loss-of-function or dominant-negative version of the
neuronal kinesin-I motor. It is perhaps surprising that
the mutation we identified affects an amino acid residue
previously shown to be crucial to motor function in both
genetic and biochemical studies of kinesin proteins. Al-
though we cannot exclude serendipity, we favor the hy-
pothesis that this human mutation represents a naturally
occurring dominant-negative allele, which would rep-
resent the type of mutation identified in genetic screens
and employed in biochemical studies requiring a stable
but nonfunctional protein. In this context, KIF5A is
thought to participate in a heterotetrameric complex
that constitutes the kinesin motor (Goldstein and Yang
2000). A dominant-negative allele is also consistent with
the autosomal dominant inheritance of SPG10, although
other mechanisms clearly are possible (Wilkie 1994). In
any case, we postulate that this specific mutation results
in aberrant neuronal intracellular anterograde traffick-
ing of membranous organelles, possibly mitochondria,
especially affecting the longest axons of the CNS, con-
sistent with the phenotype and pathology of HSP.
Prior to the present study, the genes for 6 of the 18
SPG loci had been identified, but no unifying theme of
disease pathogenesis had emerged from these discover-
ies. An emerging connection involving mitochondrial
function has been provided by the identification of mu-
tations in genes encoding two mitochondrial proteins:
HSP60 (MIM 118190), in SPG13 (MIM 605280), and
paraplegin, in SPG7 (MIM 602783). The discovery of
a mutation in a kinesin motor protein in SPG10 suggests
a potential unifying theme for the pathogenesis of
HSP—namely, disruption of mitochondrial function in
the distal ends of the longest axons of the CNS. In some
cases, including SPG10, this might be due to impairment
of neuronal axoplasmic transport of mitochondria. In
support of this, the gene encoding spastin, mutated in
the most common form of autosomal dominant HSP
(SPG4), may also be involved in axonal transport, based
on its role in microtubule dynamics (Errico et al. 2002).
The underlying pathology for a number of forms of HSP
and other long-axon neuropathies may involve a com-
mon physiological pathway of anterograde and/or ret-
rograde axoplasmic flow that, when perturbed, leads to
axonal degeneration, especially in the longest axons of
the CNS.
Note added in proof.—A 19th locus for HSP has re-
cently been identified, by Patel et al. (2002).
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